Lead Sponsor
Associate Sponsors
Supporting Partner
EU’s Pharma Event for Advancing Patient-Focused Research
The 6th annual Patients as Partners in Medicines Development Europe conference will bring together pharma, biotech, CROs and technologists to figure out how to advance patient involvement in medicines development. Experts from Novartis, Pfizer, Merck, EMD Serono, Janssen, Johnson & Johnson, GSK, Ipsen, UCB, Takeda, AbbVie, Noema Pharma, Gilead Sciences, and Pierre Fabre will gather with patient advocacy to address:
- Outcome measures that matter most to patients
- Patient Experience Data for regulatory submissions
- Compliance barriers to advance patient involvement
- Increasing diversity in clinical research
- Patient involvement in Turkey and Eastern Europe
- Impacting clinical research through carer Input
- Patient involvement in the design and execution of platform trials
- Patient access to research through digital innovation
|
Gain access |
|
Learn from |
|
Network |
Small-group interactive discussions: providing an opportunity to network with industry colleagues and to have your voices heard on a range of different topics
Rotating Sessions: A choice of interactive moderated topics where attendees can rotate between 4 sessions
Virtual Face-To-Face Networking: A wide selection of breakout Q&A sessions with companies providing solutions for patient involvement in medicines development
Covid has made the public more aware of clinical trials, patients want their voices heard, calls for diversity have grown louder, and regulators continue to raise the bar. As more and more companies embed the patient voice in every aspect of medicines development, leaders are interested in guidance and best practices to continue moving the needle.
How do we design patient-centered assessment tools that are fit-for-purpose for regulatory and payer use? What are the guidelines for collecting and reporting patient-experience data? How do we advance patient access to research through digital technology and enable diverse representation? In short, how do we stay ahead of the curve and continue to evolve as an industry?
Join the conversation early and become part of the Patients as Partners EU community by following us on LinkedIn and following the conference hashtag #PatientsEU2022. If you are interested in participating in the Patients as Partners EU 2022 program, please contact us at service@tcfllc.org.
Sincerely,
Mark Scherzer |
Valerie Bowling |
Meredith Sands |
Allyson Adams |
Adam Kolanko |
Elizabeth Bard |
Meg Gould |
Shelby Casabura |
Testimonials
"It was wonderful to have the opportunity to share with the audience our story and my role as one supporting an individual with what at times can be a very debilitating condition."
- Al and Grace Samuels, Prostate Cancer Survivor & Caregiver
"Huge congratulations to the whole team for a great event. Thank you for being so welcoming, and for not just giving lip service to patient involvement but really living it out. Looking forward to next year already! "
- Natasha Ratcliffe, Parkinsons's UK
"Overall really enjoyed the 2 days and connecting back with the reasons why industry exists and re-opening people's eyes to the big honest challenges that aren't always comfortable to hear."
- Louise Evans, Bannga Partners
"I enjoyed the fact that there was a higher representation from patient groups than other conferences and these groups were engaged in the dialogue."
- Sherina Kuruvilla, Novo Nordisk
"The audience was well invited: patients, agencies, pharma industry (even within the industry several departments lie RA, MA, clinical researchers) ALL with patient focus. "
- Theodora Weisz, Akcea Therapeutics